Skip to main content
. 2020 Feb 11;20:64. doi: 10.1186/s12887-020-1962-0

Table 4.

Factors of gastrointestinal perforation stratified by fluoroquinolones subgroup in different tracking period by using Cox regression

Tracking period Fluoroquinolones subgroup Populations Events PDs Rate (per 105 PDs) Adjusted HR 95% CI 95% CI P Adjusted HR 95% CI 95% CI P
3-day Without 133,684 2 23,707,602.75 0.01 Reference Reference
With 33,421 0 5,940,776.06 0.00 0.000 0.995
 Levofloxacin 653 0 112,735.69 0.00 0.000 0.960
 Ciprofloxaxin 1843 0 316,411.56 0.00 0.000 0.978
 Moxifloxacin 139 0 24,500.00 0.00 0.000 0.988
 Gemifloxacin 12 0 2160.00 0.00 0.000 0.998
 Norfloxacin 7041 0 1,261,596.87 0.00 0.000 0.996
 Ofloxacin 23,733 0 4,223,371.94 0.00 0.000 0.990
7-day Without 133,684 6 23,707,602.75 0.03 Reference Reference
With 33,421 1 5,940,776.06 0.02 0.512 0.080 27.426 0.756
 Levofloxacin 653 0 112,735.69 0.00 0.000 0.982
 Ciprofloxaxin 1843 0 316,411.56 0.00 0.000 0.979
 Moxifloxacin 139 0 24,500.00 0.00 0.000 0.993
 Gemifloxacin 12 0 2160.00 0.00 0.000 0.986
 Norfloxacin 7041 0 1,261,596.87 0.00 0.000 0.978
 Ofloxacin 23,733 1 4,223,371.94 0.02 0.776 0.114 72.301 0.442
14-day Without 133,684 10 23,707,602.75 0.04 Reference Reference
With 33,421 3 5,940,776.06 0.05 1.025 0.044 1.356 0.111
 Levofloxacin 653 0 112,735.69 0.00 0.000 0.986
 Ciprofloxaxin 1843 1 316,411.56 0.32 1.572 0.052 7.166 0.678
 Moxifloxacin 139 0 24,500.00 0.00 0.000 0.995
 Gemifloxacin 12 0 2160.00 0.00 0.000 0.986
 Norfloxacin 7041 1 1,261,596.87 0.08 1.342 0.020 6.988 0.501
 Ofloxacin 23,733 1 4,223,371.94 0.02 0.427 0.035 4.972 0.494
28-day Without 133,684 14 23,707,602.75 0.06 Reference Reference
With 33,421 4 5,940,776.06 0.07 1.137 0.090 1.498 0.157
 Levofloxacin 653 0 112,735.69 0.00 0.000 0.978
 Ciprofloxaxin 1843 1 316,411.56 0.32 1.266 0.028 2.999 0.267
 Moxifloxacin 139 0 24,500.00 0.00 0.000 0.978
 Gemifloxacin 12 0 2160.00 0.00 0.000 0.964
 Norfloxacin 7041 1 1,261,596.87 0.08 2.052 0.184 22.485 0.532
 Ofloxacin 23,733 2 4,223,371.94 0.05 0.307 0.555 1.752 0.188
3-month Without 133,684 45 23,707,602.75 0.19 Reference Reference
With 33,421 12 5,940,776.06 0.20 1.049 0.156 1.925 0.198
 Levofloxacin 653 0 112,735.69 0.00 0.000 0.952
 Ciprofloxaxin 1843 1 316,411.56 0.32 1.076 0.013 1.972 0.129
 Moxifloxacin 139 0 24,500.00 0.00 0.000 0.978
 Gemifloxacin 12 0 2160.00 0.00 0.000 0.986
 Norfloxacin 7041 3 1,261,596.87 0.24 1.472 0.402 5.411 0.524
 Ofloxacin 23,733 8 4,223,371.94 0.19 0.390 0.145 1.786 0.379
6-month Without 133,684 68 23,707,602.75 0.29 Reference Reference
With 33,421 17 5,940,776.06 0.29 1.330 0.778 2.276 0.255
 Levofloxacin 653 0 112,735.69 0.00 0.000 0.975
 Ciprofloxaxin 1843 1 316,411.56 0.32 1.402 0.197 10.121 0.702
 Moxifloxacin 139 0 24,500.00 0.00 0.000 0.966
 Gemifloxacin 12 0 2160.00 0.00 0.000 0.973
 Norfloxacin 7041 3 1,261,596.87 0.24 0.911 0.348 3.526 0.813
 Ofloxacin 23,733 13 4,223,371.94 0.31 1.442 0.793 2.601 0.199

PDs Person-days, Adjusted HR Adjusted hazard ratio: Adjusted for the variables listed in Table 2, CI Confidence interval